Experience with thoracic endovascular aortic repair
applied in treating Stanford type B aortic dissection:
An analysis of 98 cases

Chen, Lei; Yang, Shengjia; Guo, Fei; Zhang, Qingyun; Yang, Zhi

doi:10.17219/acem/70453

Cited by 3 publications

(3 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The total number of patients included in the analysis was 16,104 and data was extracted from 89 studies 4–92 . Among them, 7772 patients were categorized as co‐TBAD and 8352 as un‐TBAD.…”

Section: Resultsmentioning

confidence: 99%

TEVAR for complicated and uncomplicated type B aortic dissection—Systematic review and meta‐analysis

Howard

Sheridan

Picca

et al. 2021

Journal of Cardiac Surgery

View full text Add to dashboard Cite

Background: Type B aortic dissection (TBAD), is defined as a dissection involving the aorta distal to left subclavian artery with the ascending aorta and the aortic arch not affected. TBAD is classified due to the time frame and presence of complications. Complicated TBAD (co-TBAD) patients have a greater mortality rate than uncomplicated TBAD (un-TBAD) and thoracic endovascular aortic repair (TEVAR) is considered the gold-standard intervention for these clinical challenges.Methods: We undertook a systematic review of the literature regarding TEVAR intervention in co-TBAD and un-TBAD. A comprehensive search was undertaken across four major databases and was evaluated and assessed until June 2020.Results: A total of 16,104 patients were included in the study (7772 patients co-TBAD and 8352 un-TBAD). A significantly higher proportion of comorbidities were seen in co-TBAD patients compared with un-TBAD. Acute dissection was more frequent in the co-TBAD group (73.55% vs. 66.91%), while chronic dissection was more common in un-TBAD patients (33.8% vs. 70.73%). Postprocedure stroke was higher in co-TBAD (5.85% vs. 3.92%; p < .01), while postprocedural renal failure was higher in un-TBAD patients (7.23 vs. 11.38%; p < .01). No difference was observed in in-hospital mortality however the 30 days mortality was higher in the co-TBAD group. One-year survival was higher in the uncomplicated group but this difference was not observed in the 5-year survival. Conclusion:In our analysis we can appreciate that despite significantly higher comorbidities in the co-TBAD cohort, there was no difference in in-hospital mortality between the two groups and the 5-year survival did not have any difference.

show abstract

Section: Resultsmentioning

confidence: 99%

TEVAR for complicated and uncomplicated type B aortic dissection—Systematic review and meta‐analysis

Howard

Sheridan

Picca

et al. 2021

Journal of Cardiac Surgery

View full text Add to dashboard Cite

show abstract

“…Faure [43] 2014 (2000-2011) France Montpellier SC 12.2 41 66 NR 34 NR Idrees [44] 2014 (2000-2012) USA Cleveland, Ohio SC 48 766 NR 65 NR NR Zhang [45] 2014 (1998-2012) China Shanghai SC 58.4 252 54.1 NR 206 NR Gorlitzer [46] 2012 (2005-2011) Austria, Switzerland Vienna, Bern IMC NR 29 NR 62 NR 2 Huang [47] 2013 (2004-2011) China Guangzhou SC NR 563 54.09 62.75 485 3 Cochernnec [48] 2013 (2004-2011) France Creteil SC 24.5 17 60 63.75 11 2 Shuyang Lu [49] 2012 [50] 2012 (2006-2011) Taiwan Taipei SC 24.1 61 62.7 NR 51 NR Bunger [51] 2013 (2006-2012) Germany Rostock SC 27.9 45 59.9 55 38 1 Canaud [52] 2014 (2002-2012) UK London SC NR 309 63.1 NR 248 NR Lombardi [53] 2012 [56] 2014 (2005-2012) USA North Carolina SC 34.1 50 59 NR 36 NR De Rango [57] 2014 (2005-2013) Italy Rome, Perugia NMC 29.2 104 69.8 NR 90 NR Appoo [58] 2015 (2008-2012) Canada Alberta SC 72 16 63.8 NR NR NR Desai [59] 2015 (2005-2012) USA Philadelphia SC 132 64.1 NR 80 NR Kische [60] 2015 (2009-2015) Germany Berlin, Rostock NMC 25.6 35 63 NR 27 NR Bockler [61] 2016 (2009-2010) Germany, UK, Italy, Sweden Multicenter IMC 24 24 NR NR NR NR Faure [62] 2016 (2005-2015) France Montpellier SC 24.3 33 65.1 62 26 1 Wang [63] 2016 (2005-2013) China Zhengzhou SC 32 360 52 51.8 304 4 Asaloumidis [64] 2017 (2000-2014) Greece Thessaloniki SC 74 40 65 NR 33 NR Zhao Liu [65] 2017 Zhang [66] 2017 Laquian [69] 2018 (2011-2014) USA Florida, Alabama NMC 17.9 27 63 NR 17 NR Chen [70] 2018 (2007-2014) China Hebei, Beijing NMC 17.9 167 NR NR 112 NR Piotr Buczkowski [71] 2019 (2007-2017) Poland Poznan SC 55 68 NR NR NR NR Eleshra [72] 2020 (2010-2017) Germany Hamburg SC 28 64 64.8 NR 49 NR Fukushima [73] 2019 (2011-2017) Japan Chiba SC 14.2 24 67.7 NR 21 NR Wang [74] 2019 (2013-2014) USA Multicenter IMC 1 397 60.4 NR 286 NR Yammine [17] 2019 (2012-2017) USA North Carolina SC 14.25 186 61.6 61.5 112 8 Miura [75] 2019 ...…”

Section: Resultsmentioning

confidence: 99%

“…The literature search yielded 1963 potentially eligible articles. After considering our selection criteria, 78 eligible clinical studies [4,5,8,10,12,14,17,25–95] published between 2002 and 2020 were enrolled in the qualitative and quantitative analysis (Fig. 1).…”

Section: Resultsmentioning

confidence: 99%

A systematic review and meta-analysis of retrograde type A aortic dissection after thoracic endovascular aortic repair in patients with type B aortic dissection

et al. 2023

View full text Add to dashboard Cite

Background: Retrograde type A dissection (RTAD) is a devastating complication of thoracic endovascular repair (TEVAR) with low incidence but high mortality. The objective of this study is to report the incidence, mortality, potential risk factors, clinical manifestation and diagnostic modalities, and medical and surgical treatments. Methods: A systematic review and single-arm and two-arm meta-analyses evaluated all published reports of RTAD post-TEVAR through January 2021. All study types were included, except study protocols and animal studies, without time restrictions. Outcomes of interest were procedural data (implanted stent-grafts type, and proximal stent-graft oversizing), the incidence of RTAD, associated mortality rate, clinical manifestations, diagnostic workouts and therapeutic management. Results: RTAD occurred in 285 out of 10,600 patients: an estimated RTAD incidence of 2.3% (95% CI: 1.9–2.8); incidence of early RTAD was approximately 1.8 times higher than late. Wilcoxon signed-rank testing showed that the proportion of RTAD patients with acute type B aortic dissection (TBAD) was significantly higher than those with chronic TBAD ( P = .008). Pooled meta-analysis showed that the incidence of RTAD with proximal bare stent TEVAR was 2.1-fold higher than with non-bare stents: risk ratio was 1.55 (95% CI: 0.87–2.75; P = .13). Single arm meta-analysis estimated a mortality rate of 42.2% (95% CI: 32.5–51.8), with an I 2 heterogeneity of 70.11% ( P < .001). Conclusion: RTAD is rare after TEVAR but with high mortality, especially in the first month post-TEVAR with acute TBAD patients at greater risk as well as those treated with proximal bare stent endografts.

show abstract

Conservative Treatment of Retrograde Aortic Dissection after Endovascular or Hybrid repair of descending aorta pathologies

Borghese,

Vincenzoni,

Nocerino

et al. 2024

Annals of Vascular Surgery

View full text Add to dashboard Cite

Experience with thoracic endovascular aortic repair applied in treating Stanford type B aortic dissection: An analysis of 98 cases

Abstract: TEVAR is reliable and safe, and it can be widely applied in treating Stanford type B aortic dissection.

Cited by 3 publications

References 10 publications

TEVAR for complicated and uncomplicated type B aortic dissection—Systematic review and meta‐analysis

TEVAR for complicated and uncomplicated type B aortic dissection—Systematic review and meta‐analysis

A systematic review and meta-analysis of retrograde type A aortic dissection after thoracic endovascular aortic repair in patients with type B aortic dissection

Conservative Treatment of Retrograde Aortic Dissection after Endovascular or Hybrid repair of descending aorta pathologies

Contact Info

Product

Resources

About